Clyde & Co | Risky Business
Clyde & Co | Risky Business
Podcast Description
In the "Risky business with Clyde & Co" podcast series, partners and associates in the dispute resolution team in London reflect on a wide range risk and related issues that arise when businesses are in conflict, or are looking to manage and avoid potential conflict.
Podcast Insights
Content Themes
This podcast focuses on legal risks associated with commercial disputes, including topics like litigation financing, smart contracts, and the nuances of contract novation. Episodes explore specific legal cases, such as the recent discussions surrounding novation in shareholders' agreements and the implications of the Supreme Court's decision in commercial contracts, creating a rich tapestry of legal analysis and practical guidance for listeners.
In the “Risky business with Clyde & Co” podcast series, partners and associates in the dispute resolution team in London reflect on a wide range risk and related issues that arise when businesses are in conflict, or are looking to manage and avoid potential conflict.
In this episode, Hashem Hijjawi and Camille Lukusa from Clyde & Co LLP’s Global Dispute Resolution team explore the concept of Norwich Pharmacal orders, a legal tool used to compel third parties to disclose information necessary to identify wrongdoers. They explain the origins of this relief in the 1974 House of Lords case of Norwich Pharmacal Co v Customs and Excise Commissioners, where the court held that justice required HMRC to disclose the identities of patent infringers.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.